N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis.
Ontology highlight
ABSTRACT: Oxidative stress is a common feature of tuberculosis (TB), and persons with reduced antioxidants are at more risk of TB. TB patients with relatively severe oxidative stress had also more advanced disease as measured by the Karnofsky performance index. Since adverse effects from anti-TB drugs are also mediated by free radicals, TB patients are prone to side effects, such as hearing loss. In previous articles, researchers appealed for clinical trials aiming at evaluating N-acetyl cysteine (NAC) in attenuating the dreaded hearing loss during multidrug-resistant TB (MDR-TB) treatment. However, before embarking on such trials, considerations of NAC's overall impact on TB treatment are crucial. Unfortunately, such a comprehensive report on NAC is missing in the literature and this manuscript rev
SUBMITTER: Ejigu DA
PROVIDER: S-EPMC7210531 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA